AIxplorer Biotech, AliveX Biotech and Zizhan Pharmaceuticals announced a strategic collaboration to jointly develop precision medicine for the treatment of inflammatory bowel disease (IBD)

Source:AIxplorerBio Time:2021-12-23

(Shanghai, China, 23 December 2021) AIxplorer Biotech, AliveX Biotech, and Zizhan Pharma entered into a framework collaboration agreement, three parties co-created IBD Alliance to advance the discovery and development of precision medicine for IBD. This strategic collaboration will leverage the technological and scientific strengths of three companies, jointly advancing the preclinical studies and IND filing in both U.S. and China.      

Signing ceremony: from left to right, AliveX Biotech CEO Shirley Wen, AIxplorer Biotech CEO Dr.David Xu, Zizhan Pharma CEO Dr.Zhen Min